Quality of life among people living with HIV in England and the Netherlands: a population-based study
HIV is now considered a chronic condition, and people living with HIV, when treated, have a similar life expectancy as compared to the general population. Consequently, improving and ensuring a good health-related quality of life (HrQoL) among people living with HIV (people living with HIV) is incre...
Uložené v:
| Vydané v: | The Lancet regional health. Europe Ročník 8; s. 100177 |
|---|---|
| Hlavní autori: | , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
England
Elsevier Ltd
01.09.2021
Elsevier |
| Predmet: | |
| ISSN: | 2666-7762, 2666-7762 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | HIV is now considered a chronic condition, and people living with HIV, when treated, have a similar life expectancy as compared to the general population. Consequently, improving and ensuring a good health-related quality of life (HrQoL) among people living with HIV (people living with HIV) is increasingly important and has risen on the global agenda in recent years. A ‘fourth 90’ as 90% of people with viral load suppression have a good HrQoL should therefore be adopted alongside the other 90-90-90 targets. This study aims to report the progress on HrQoL as the ‘fourth 90’ and compare against the general population in the Netherlands and England.
In the Netherlands, individuals attending the HIV outpatient clinic of a tertiary hospital were asked to complete the EQ-5D-5L from June 2016 until December 2018. In England, individuals attending one of 73 HIV outpatient clinics were randomly sampled to complete the Positive Voices survey, which included the EQ-5D-5L, from January to September 2017. HrQoL scores were combined with demographic data and compared to general population data.
The EQ-5D-5L was filled-out by 895 people living with HIV in the NL and 4,137 in England. HrQoLutility was 0·85 among Dutch and 0·83 among English people living with HIV. This equated to 98% and 94% of the general population HrQoLutility in the Netherlands and England, respectively. Of the EQ-5D domains, anxiety/depression was mostly affected, with one-third in Dutch (35%) and almost half (47%) of English people living with HIV reporting symptoms. This was higher compared to their respective general populations (21% NL and 31% England).
Overall, HrQoLutility for people living with HIV was high in both countries and highly comparable to the general populations Nevertheless, there should be an increased focus on anxiety and depression in the people living with HIV population The EQ-5D-5L proved an easy HrQoL measurement tool and identified areas for improvement by social and behavioural interventions.
The study received funding (unrestricted grants) from: Gilead sciences, ViiV Healthcare, MSD, and Jansen pharmaceuticals. |
|---|---|
| AbstractList | AbstractBackgroundHIV is now considered a chronic condition, and people living with HIV, when treated, have a similar life expectancy as compared to the general population. Consequently, improving and ensuring a good health-related quality of life (HrQoL) among people living with HIV (people living with HIV) is increasingly important and has risen on the global agenda in recent years. A ‘fourth 90’ as 90% of people with viral load suppression have a good HrQoL should therefore be adopted alongside the other 90-90-90 targets. This study aims to report the progress on HrQoL as the ‘fourth 90’ and compare against the general population in the Netherlands and England. MethodsIn the Netherlands, individuals attending the HIV outpatient clinic of a tertiary hospital were asked to complete the EQ-5D-5L from June 2016 until December 2018. In England, individuals attending one of 73 HIV outpatient clinics were randomly sampled to complete the Positive Voices survey, which included the EQ-5D-5L, from January to September 2017. HrQoL scores were combined with demographic data and compared to general population data. FindingsThe EQ-5D-5L was filled-out by 895 people living with HIV in the NL and 4,137 in England. HrQoL utility was 0·85 among Dutch and 0·83 among English people living with HIV. This equated to 98% and 94% of the general population HrQoL utility in the Netherlands and England, respectively. Of the EQ-5D domains, anxiety/depression was mostly affected, with one-third in Dutch (35%) and almost half (47%) of English people living with HIV reporting symptoms. This was higher compared to their respective general populations (21% NL and 31% England). InterpretationOverall, HrQoL utility for people living with HIV was high in both countries and highly comparable to the general populations Nevertheless, there should be an increased focus on anxiety and depression in the people living with HIV population The EQ-5D-5L proved an easy HrQoL measurement tool and identified areas for improvement by social and behavioural interventions. FundingThe study received funding (unrestricted grants) from: Gilead sciences, ViiV Healthcare, MSD, and Jansen pharmaceuticals. HIV is now considered a chronic condition, and people living with HIV, when treated, have a similar life expectancy as compared to the general population. Consequently, improving and ensuring a good health-related quality of life (HrQoL) among people living with HIV (people living with HIV) is increasingly important and has risen on the global agenda in recent years. A ‘fourth 90’ as 90% of people with viral load suppression have a good HrQoL should therefore be adopted alongside the other 90-90-90 targets. This study aims to report the progress on HrQoL as the ‘fourth 90’ and compare against the general population in the Netherlands and England. In the Netherlands, individuals attending the HIV outpatient clinic of a tertiary hospital were asked to complete the EQ-5D-5L from June 2016 until December 2018. In England, individuals attending one of 73 HIV outpatient clinics were randomly sampled to complete the Positive Voices survey, which included the EQ-5D-5L, from January to September 2017. HrQoL scores were combined with demographic data and compared to general population data. The EQ-5D-5L was filled-out by 895 people living with HIV in the NL and 4,137 in England. HrQoLutility was 0·85 among Dutch and 0·83 among English people living with HIV. This equated to 98% and 94% of the general population HrQoLutility in the Netherlands and England, respectively. Of the EQ-5D domains, anxiety/depression was mostly affected, with one-third in Dutch (35%) and almost half (47%) of English people living with HIV reporting symptoms. This was higher compared to their respective general populations (21% NL and 31% England). Overall, HrQoLutility for people living with HIV was high in both countries and highly comparable to the general populations Nevertheless, there should be an increased focus on anxiety and depression in the people living with HIV population The EQ-5D-5L proved an easy HrQoL measurement tool and identified areas for improvement by social and behavioural interventions. The study received funding (unrestricted grants) from: Gilead sciences, ViiV Healthcare, MSD, and Jansen pharmaceuticals. Background: HIV is now considered a chronic condition, and people living with HIV, when treated, have a similar life expectancy as compared to the general population. Consequently, improving and ensuring a good health-related quality of life (HrQoL) among people living with HIV (people living with HIV) is increasingly important and has risen on the global agenda in recent years. A ‘fourth 90’ as 90% of people with viral load suppression have a good HrQoL should therefore be adopted alongside the other 90-90-90 targets. This study aims to report the progress on HrQoL as the ‘fourth 90’ and compare against the general population in the Netherlands and England. Methods: In the Netherlands, individuals attending the HIV outpatient clinic of a tertiary hospital were asked to complete the EQ-5D-5L from June 2016 until December 2018. In England, individuals attending one of 73 HIV outpatient clinics were randomly sampled to complete the Positive Voices survey, which included the EQ-5D-5L, from January to September 2017. HrQoL scores were combined with demographic data and compared to general population data. Findings: The EQ-5D-5L was filled-out by 895 people living with HIV in the NL and 4,137 in England. HrQoLutility was 0·85 among Dutch and 0·83 among English people living with HIV. This equated to 98% and 94% of the general population HrQoLutility in the Netherlands and England, respectively. Of the EQ-5D domains, anxiety/depression was mostly affected, with one-third in Dutch (35%) and almost half (47%) of English people living with HIV reporting symptoms. This was higher compared to their respective general populations (21% NL and 31% England). Interpretation: Overall, HrQoLutility for people living with HIV was high in both countries and highly comparable to the general populations Nevertheless, there should be an increased focus on anxiety and depression in the people living with HIV population The EQ-5D-5L proved an easy HrQoL measurement tool and identified areas for improvement by social and behavioural interventions. Funding: The study received funding (unrestricted grants) from: Gilead sciences, ViiV Healthcare, MSD, and Jansen pharmaceuticals. HIV is now considered a chronic condition, and people living with HIV, when treated, have a similar life expectancy as compared to the general population. Consequently, improving and ensuring a good health-related quality of life (HrQoL) among people living with HIV (people living with HIV) is increasingly important and has risen on the global agenda in recent years. A 'fourth 90' as 90% of people with viral load suppression have a good HrQoL should therefore be adopted alongside the other 90-90-90 targets. This study aims to report the progress on HrQoL as the 'fourth 90' and compare against the general population in the Netherlands and England. In the Netherlands, individuals attending the HIV outpatient clinic of a tertiary hospital were asked to complete the EQ-5D-5L from June 2016 until December 2018. In England, individuals attending one of 73 HIV outpatient clinics were randomly sampled to complete the Positive Voices survey, which included the EQ-5D-5L, from January to September 2017. HrQoL scores were combined with demographic data and compared to general population data. The EQ-5D-5L was filled-out by 895 people living with HIV in the NL and 4,137 in England. HrQoL was 0·85 among Dutch and 0·83 among English people living with HIV. This equated to 98% and 94% of the general population HrQoL in the Netherlands and England, respectively. Of the EQ-5D domains, anxiety/depression was mostly affected, with one-third in Dutch (35%) and almost half (47%) of English people living with HIV reporting symptoms. This was higher compared to their respective general populations (21% NL and 31% England). Overall, HrQoL for people living with HIV was high in both countries and highly comparable to the general populations Nevertheless, there should be an increased focus on anxiety and depression in the people living with HIV population The EQ-5D-5L proved an easy HrQoL measurement tool and identified areas for improvement by social and behavioural interventions. The study received funding (unrestricted grants) from: Gilead sciences, ViiV Healthcare, MSD, and Jansen pharmaceuticals. HIV is now considered a chronic condition, and people living with HIV, when treated, have a similar life expectancy as compared to the general population. Consequently, improving and ensuring a good health-related quality of life (HrQoL) among people living with HIV (people living with HIV) is increasingly important and has risen on the global agenda in recent years. A 'fourth 90' as 90% of people with viral load suppression have a good HrQoL should therefore be adopted alongside the other 90-90-90 targets. This study aims to report the progress on HrQoL as the 'fourth 90' and compare against the general population in the Netherlands and England.BACKGROUNDHIV is now considered a chronic condition, and people living with HIV, when treated, have a similar life expectancy as compared to the general population. Consequently, improving and ensuring a good health-related quality of life (HrQoL) among people living with HIV (people living with HIV) is increasingly important and has risen on the global agenda in recent years. A 'fourth 90' as 90% of people with viral load suppression have a good HrQoL should therefore be adopted alongside the other 90-90-90 targets. This study aims to report the progress on HrQoL as the 'fourth 90' and compare against the general population in the Netherlands and England.In the Netherlands, individuals attending the HIV outpatient clinic of a tertiary hospital were asked to complete the EQ-5D-5L from June 2016 until December 2018. In England, individuals attending one of 73 HIV outpatient clinics were randomly sampled to complete the Positive Voices survey, which included the EQ-5D-5L, from January to September 2017. HrQoL scores were combined with demographic data and compared to general population data.METHODSIn the Netherlands, individuals attending the HIV outpatient clinic of a tertiary hospital were asked to complete the EQ-5D-5L from June 2016 until December 2018. In England, individuals attending one of 73 HIV outpatient clinics were randomly sampled to complete the Positive Voices survey, which included the EQ-5D-5L, from January to September 2017. HrQoL scores were combined with demographic data and compared to general population data.The EQ-5D-5L was filled-out by 895 people living with HIV in the NL and 4,137 in England. HrQoLutility was 0·85 among Dutch and 0·83 among English people living with HIV. This equated to 98% and 94% of the general population HrQoLutility in the Netherlands and England, respectively. Of the EQ-5D domains, anxiety/depression was mostly affected, with one-third in Dutch (35%) and almost half (47%) of English people living with HIV reporting symptoms. This was higher compared to their respective general populations (21% NL and 31% England).FINDINGSThe EQ-5D-5L was filled-out by 895 people living with HIV in the NL and 4,137 in England. HrQoLutility was 0·85 among Dutch and 0·83 among English people living with HIV. This equated to 98% and 94% of the general population HrQoLutility in the Netherlands and England, respectively. Of the EQ-5D domains, anxiety/depression was mostly affected, with one-third in Dutch (35%) and almost half (47%) of English people living with HIV reporting symptoms. This was higher compared to their respective general populations (21% NL and 31% England).Overall, HrQoLutility for people living with HIV was high in both countries and highly comparable to the general populations Nevertheless, there should be an increased focus on anxiety and depression in the people living with HIV population The EQ-5D-5L proved an easy HrQoL measurement tool and identified areas for improvement by social and behavioural interventions.INTERPRETATIONOverall, HrQoLutility for people living with HIV was high in both countries and highly comparable to the general populations Nevertheless, there should be an increased focus on anxiety and depression in the people living with HIV population The EQ-5D-5L proved an easy HrQoL measurement tool and identified areas for improvement by social and behavioural interventions.The study received funding (unrestricted grants) from: Gilead sciences, ViiV Healthcare, MSD, and Jansen pharmaceuticals.FUNDINGThe study received funding (unrestricted grants) from: Gilead sciences, ViiV Healthcare, MSD, and Jansen pharmaceuticals. |
| ArticleNumber | 100177 |
| Author | Popping, Stephanie van de Vijver, David. A.M.C. Stempher, Evelien van Sighem, Ard Nichols, Brooke E. Versteegh, M. Verbon, Annelies Delpech, Valerie Boucher, Charles Versteegh, Lisbeth Kall, Meaghan |
| Author_xml | – sequence: 1 givenname: Stephanie orcidid: 0000-0002-8959-4671 surname: Popping fullname: Popping, Stephanie email: s.popping@erasmusmc.nl organization: Erasmus Medical Centre, Rotterdam, Department of Viroscience, The Netherlands – sequence: 2 givenname: Meaghan surname: Kall fullname: Kall, Meaghan email: Meaghan.kall@phe.gov.uk organization: HIV and STI Department, National Infection Service, Public Health England, London, United Kingdom – sequence: 3 givenname: Brooke E. orcidid: 0000-0003-4682-4999 surname: Nichols fullname: Nichols, Brooke E. organization: Erasmus Medical Centre, Rotterdam, Department of Viroscience, The Netherlands – sequence: 4 givenname: Evelien orcidid: 0000-0002-2636-1256 surname: Stempher fullname: Stempher, Evelien organization: Erasmus Medical Centre, Rotterdam, Department of Viroscience, The Netherlands – sequence: 5 givenname: Lisbeth surname: Versteegh fullname: Versteegh, Lisbeth organization: Erasmus Medical Centre, Rotterdam, Department of Viroscience, The Netherlands – sequence: 6 givenname: David. A.M.C. surname: van de Vijver fullname: van de Vijver, David. A.M.C. organization: Erasmus Medical Centre, Rotterdam, Department of Viroscience, The Netherlands – sequence: 7 givenname: Ard surname: van Sighem fullname: van Sighem, Ard organization: Stichting HIV monitoring, Amsterdam, The Netherlands – sequence: 8 givenname: M. orcidid: 0000-0003-4804-235X surname: Versteegh fullname: Versteegh, M. organization: institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam – sequence: 9 givenname: Charles surname: Boucher fullname: Boucher, Charles organization: Erasmus Medical Centre, Rotterdam, Department of Viroscience, The Netherlands – sequence: 10 givenname: Valerie surname: Delpech fullname: Delpech, Valerie organization: HIV and STI Department, National Infection Service, Public Health England, London, United Kingdom – sequence: 11 givenname: Annelies surname: Verbon fullname: Verbon, Annelies email: a.verbon@umcutrecht.nl organization: Erasmus Medical Centre, Rotterdam, Department of Medical Microbiology and Infectious Diseases |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34557859$$D View this record in MEDLINE/PubMed |
| BookMark | eNqVkl1rFDEUhgep2Fr7D0Ry6c2uSSYfM0UEKdUuFEX8wLuQyZzZzZpNxmRmZf-9me5WWkGKF_k6Oed54Zz3aXHkg4eieE7wnGAiXq3nTnvoYU4xJTmEiZSPihMqhJhJKejRnftxcZbSGmNMOSkpYU-K45JxLitenxTwadTODjsUOuRsB0hvgl-iHkLvIEe2Nr9-2WGFrhbfkPXo0i-zdIumNawAfYC8xymUzpFGfehHpwcb_KzRCVqUhrHdPSsed9olODucp8XXd5dfLq5m1x_fLy7eXs-MKOUwY5rVWkvJBSO60lVbloSJWjIA3Qnomk7gjjJds0aLsqxbThtDDcFdWUvS6PK0WOy5bdBr1Ue70XGngrbqJhDiUuk4WONA8arDHGdSvrC2E1XV1AyYMbhqSdNUmfVmz-rHZgOtAT9E7e5B7_94u1LLsFUV44xXMgNeHgAx_BwhDWpjkwE3TS6MSVEuheB5nJPWi7taf0Ru55QTzvcJJoaUInTK2OGmzVnaOkWwmnyh1mrvCzX5Qu19kYvZX8W3_AfKDg2APLGthaiSseANtDaCGXJL7f8CjLPeGu1-wA7SOozRZzcoohJVWH2eHDsZlk71nH3PgNf_Bjys_xtI4Pz4 |
| CitedBy_id | crossref_primary_10_3389_fmed_2024_1380731 crossref_primary_10_3389_fpubh_2024_1383743 crossref_primary_10_1089_regen_2024_0005 crossref_primary_10_1080_09540121_2024_2307381 crossref_primary_10_1080_14728222_2024_2351510 crossref_primary_10_1002_hep4_1958 crossref_primary_10_1038_s41598_023_43434_x crossref_primary_10_1186_s12955_023_02120_2 crossref_primary_10_4102_phcfm_v16i1_4519 crossref_primary_10_1164_rccm_202411_2213OC crossref_primary_10_1590_1413_81232025305_18862023en crossref_primary_10_1080_15381501_2025_2453811 crossref_primary_10_1016_j_bodyim_2025_101880 crossref_primary_10_12968_bjon_2023_32_1_S12 crossref_primary_10_1111_jan_15941 crossref_primary_10_1007_s11136_025_03966_3 crossref_primary_10_3390_jcm13195673 crossref_primary_10_1093_inthealth_ihaf022 crossref_primary_10_1007_s11136_022_03232_w crossref_primary_10_1177_23259582231164241 crossref_primary_10_1186_s12961_024_01181_z crossref_primary_10_1177_09564624231202287 crossref_primary_10_1002_jia2_26516 crossref_primary_10_1007_s11136_023_03342_z crossref_primary_10_1186_s12913_025_12619_7 crossref_primary_10_1371_journal_pone_0304859 crossref_primary_10_3390_nursrep15030107 crossref_primary_10_1371_journal_pone_0278054 crossref_primary_10_1590_1413_81232025305_18862023 crossref_primary_10_1097_QAI_0000000000003526 |
| Cites_doi | 10.1086/649216 10.1080/09540121.2012.712669 10.2165/00019053-200624080-00003 10.1016/j.jval.2016.01.003 10.1080/09540121.2014.936813 10.1111/bjd.15280 10.1186/1477-7525-10-132 10.1002/hec.3564 10.1097/YCO.0b013e3282f32408 10.1146/annurev-clinpsy-021815-093153 10.2196/ijmr.9325 10.1016/S0140-6736(18)32462-0 10.1097/QAI.0b013e318160d53e 10.2165/00003495-200666060-00004 10.1097/01.nmd.0000120888.45094.38 10.1186/1478-7547-8-5 10.1186/1477-7525-11-42 10.1089/apc.2012.0329 10.1186/s12916-016-0640-4 10.1007/s10198-013-0502-3 10.1080/09540129650126037 10.1016/S2352-3018(14)70018-9 10.1097/QAD.0b013e32834dcec9 10.1097/QAD.0000000000001672 10.1186/s12955-017-0778-6 10.1016/0168-8510(96)00822-6 10.1186/1477-7525-11-164 10.1097/QAD.0000000000002815 10.1016/j.jhin.2017.03.004 10.1007/s40273-018-0647-0 |
| ContentType | Journal Article |
| Copyright | 2021 The Authors The Authors 2021 The Authors. 2021 The Authors 2021 |
| Copyright_xml | – notice: 2021 The Authors – notice: The Authors – notice: 2021 The Authors. – notice: 2021 The Authors 2021 |
| DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.1016/j.lanepe.2021.100177 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health |
| EISSN | 2666-7762 |
| EndPage | 100177 |
| ExternalDocumentID | oai_doaj_org_article_58f05094b58f4df688b94e4cc08d1bb8 PMC8454587 34557859 10_1016_j_lanepe_2021_100177 S266677622100154X 1_s2_0_S266677622100154X |
| Genre | Journal Article |
| GrantInformation | The study received funding (unrestricted grants) from: Gilead sciences, ViiV Healthcare, MSD, and Jansen pharmaceuticals. |
| GroupedDBID | .1- .FO 0R~ 53G AAEDW AALRI AAMRU AAXUO ACVFH ADCNI AEUPX AFPUW AFRHN AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS APXCP FDB GROUPED_DOAJ M~E OK1 ROL RPM Z5R AAHOK 6I. AAFTH AAYXX CITATION NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c637t-4a49aa775641a8a8d33146974eeaf6efbf60f24a94ba6339d52bc2c10f3971ba3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 35 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000704988300020&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2666-7762 |
| IngestDate | Fri Oct 03 12:50:14 EDT 2025 Thu Aug 21 18:18:48 EDT 2025 Fri Jul 11 07:59:57 EDT 2025 Wed Feb 19 02:26:58 EST 2025 Thu Nov 20 00:55:22 EST 2025 Tue Nov 18 21:16:18 EST 2025 Tue Jul 25 21:00:23 EDT 2023 Sun Feb 23 10:19:44 EST 2025 Tue Aug 26 16:32:06 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | people living with HIV HIV quality of life elimination goals value-based healthcare |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. 2021 The Authors. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c637t-4a49aa775641a8a8d33146974eeaf6efbf60f24a94ba6339d52bc2c10f3971ba3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Equally contributed |
| ORCID | 0000-0002-2636-1256 0000-0003-4682-4999 0000-0002-8959-4671 0000-0003-4804-235X |
| OpenAccessLink | https://doaj.org/article/58f05094b58f4df688b94e4cc08d1bb8 |
| PMID | 34557859 |
| PQID | 2576651018 |
| PQPubID | 23479 |
| PageCount | 1 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_58f05094b58f4df688b94e4cc08d1bb8 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8454587 proquest_miscellaneous_2576651018 pubmed_primary_34557859 crossref_citationtrail_10_1016_j_lanepe_2021_100177 crossref_primary_10_1016_j_lanepe_2021_100177 elsevier_sciencedirect_doi_10_1016_j_lanepe_2021_100177 elsevier_clinicalkeyesjournals_1_s2_0_S266677622100154X elsevier_clinicalkey_doi_10_1016_j_lanepe_2021_100177 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-09-01 |
| PublicationDateYYYYMMDD | 2021-09-01 |
| PublicationDate_xml | – month: 09 year: 2021 text: 2021-09-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | The Lancet regional health. Europe |
| PublicationTitleAlternate | Lancet Reg Health Eur |
| PublicationYear | 2021 |
| Publisher | Elsevier Ltd Elsevier |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
| References | MV, MV, MAAE, de Wit, Prenger, AS (bib0018) 2016; 19 Badia, Casey, Petrosillo, Hudson, Mitchell, Crosby (bib0036) 2017; 96 Nash, Croxford, Guerra, Lowndes, Connor, Gill (bib0015) 2018 de Boer-van der Kolk, Sprangers, Prins, Smit, de Wolf, Nieuwkerk (bib0022) 2010; 50 ECDC. HIV/AIDS surveillance in Europe 2019-2018 data European Centre for Disease Prevention and Control (ECDC) 2019. Cahn, Madero, Arribas, Antinori, Ortiz, Clarke (bib0011) 2019; 393 Davis, Uezato, Newell, Frazier (bib0025) 2008; 21 Chander, Himelhoch, Moore (bib0023) 2006; 66 Horberg, Silverberg, Hurley, Towner, Klein, Bersoff-Matcha (bib0024) 2008; 47 Balderson, Grothaus, Harrison, McCoy, Mahoney, Catz (bib0032) 2013; 25 Johnston, Wright, Orr, Pearce, Stevens, Hubbard (bib0039) 2021; 35 Van Sighem, Smit, Stolte, Reiss (bib0014) 2017 Cooper, Clatworthy, Harding, Whetham, Emerge (bib0006) 2017; 15 Brooks (bib0009) 1996; 37 Organization (bib0021) 2016 Simpson, Hanson, Harding, Haider, Tawadrous, Khachatryan (bib0034) 2013; 11 Devlin, Shah, Feng, Mulhern, van Hout (bib0019) 2018; 27 Nakagawa, Lodwick, Smith, Smith, Cambiano, Lundgren (bib0002) 2012; 26 Carey, Carey, Maisto, Schroder, Vanable, Gordon (bib0029) 2004; 192 Mastboom, Planje, van de Sande (bib0035) 2018; 7 Rodriguez-Penney, Iudicello, Riggs, Doyle, Ellis, Letendre (bib0031) 2013; 27 Robberstad, Olsen (bib0033) 2010; 8 Robertson, Bayon, Molina, McNamara, Resch, Munoz-Moreno (bib0030) 2014; 26 Tran, Ohinmaa, Nguyen (bib0007) 2012; 10 Wu, Hanson, Harding, Haider, Tawadrous, Khachatryan (bib0008) 2013; 11 Engelhard, Smit, PRv, Kuijper, Wermeling, Weel (bib0026) 2018; 32 Balieva, Kupfer, Lien, Gieler, Finlay, Tomas-Aragones (bib0038) 2017; 176 Clayson, Wild, Quarterman, Duprat-Lomon, Kubin, Coons (bib0004) 2006; 24 Selivanova, Buskens, Krabbe (bib0017) 2018; 36 . Russell, Fish (bib0027) 2016; 12 Digital N. Health Survey for England: NHS Digital; 2019 [Available from Miners, Phillips, Kreif, Rodger, Speakman, Fisher (bib0010) 2014; 1 (bib0013) 2015 National AIDS programmes: A guid to monitoring and evaluation UNAIDS; 2000. Grassi (bib0028) 1996; 8 Devlin, Krabbe (bib0005) 2013; 14 Lazarus, Safreed-Harmon, Barton, Costagliola, Dedes, del Amo Valero (bib0012) 2016; 14 Kall, Kelly, Auzenbergs, Delpech (bib0016) 2020 Balieva (10.1016/j.lanepe.2021.100177_bib0038) 2017; 176 (10.1016/j.lanepe.2021.100177_bib0013) 2015 Simpson (10.1016/j.lanepe.2021.100177_bib0034) 2013; 11 Lazarus (10.1016/j.lanepe.2021.100177_bib0012) 2016; 14 Engelhard (10.1016/j.lanepe.2021.100177_bib0026) 2018; 32 Robertson (10.1016/j.lanepe.2021.100177_bib0030) 2014; 26 Robberstad (10.1016/j.lanepe.2021.100177_bib0033) 2010; 8 Rodriguez-Penney (10.1016/j.lanepe.2021.100177_bib0031) 2013; 27 Davis (10.1016/j.lanepe.2021.100177_bib0025) 2008; 21 Chander (10.1016/j.lanepe.2021.100177_bib0023) 2006; 66 Mastboom (10.1016/j.lanepe.2021.100177_bib0035) 2018; 7 Cooper (10.1016/j.lanepe.2021.100177_bib0006) 2017; 15 Badia (10.1016/j.lanepe.2021.100177_bib0036) 2017; 96 10.1016/j.lanepe.2021.100177_bib0020 Selivanova (10.1016/j.lanepe.2021.100177_bib0017) 2018; 36 Balderson (10.1016/j.lanepe.2021.100177_bib0032) 2013; 25 Grassi (10.1016/j.lanepe.2021.100177_bib0028) 1996; 8 MV (10.1016/j.lanepe.2021.100177_bib0018) 2016; 19 Johnston (10.1016/j.lanepe.2021.100177_bib0039) 2021; 35 Russell (10.1016/j.lanepe.2021.100177_bib0027) 2016; 12 Kall (10.1016/j.lanepe.2021.100177_bib0016) 2020 Organization (10.1016/j.lanepe.2021.100177_bib0021) 2016 Carey (10.1016/j.lanepe.2021.100177_bib0029) 2004; 192 Brooks (10.1016/j.lanepe.2021.100177_bib0009) 1996; 37 Devlin (10.1016/j.lanepe.2021.100177_bib0019) 2018; 27 Nakagawa (10.1016/j.lanepe.2021.100177_bib0002) 2012; 26 10.1016/j.lanepe.2021.100177_bib0001 Cahn (10.1016/j.lanepe.2021.100177_bib0011) 2019; 393 10.1016/j.lanepe.2021.100177_bib0003 Miners (10.1016/j.lanepe.2021.100177_bib0010) 2014; 1 Tran (10.1016/j.lanepe.2021.100177_bib0007) 2012; 10 Nash (10.1016/j.lanepe.2021.100177_bib0015) 2018 Devlin (10.1016/j.lanepe.2021.100177_bib0005) 2013; 14 Clayson (10.1016/j.lanepe.2021.100177_bib0004) 2006; 24 Horberg (10.1016/j.lanepe.2021.100177_bib0024) 2008; 47 Van Sighem (10.1016/j.lanepe.2021.100177_bib0014) 2017 Wu (10.1016/j.lanepe.2021.100177_bib0008) 2013; 11 de Boer-van der Kolk (10.1016/j.lanepe.2021.100177_bib0022) 2010; 50 |
| References_xml | – volume: 25 start-page: 451 year: 2013 end-page: 458 ident: bib0032 article-title: Chronic illness burden and quality of life in an aging HIV population publication-title: AIDS Care – volume: 35 start-page: 957 year: 2021 end-page: 970 ident: bib0039 article-title: Worldwide relative smoking prevalence among people living with and without HIV publication-title: Aids – volume: 15 start-page: 220 year: 2017 ident: bib0006 article-title: Measuring quality of life among people living with HIV: a systematic review of reviews publication-title: Health Qual Life Outcomes – volume: 36 start-page: 715 year: 2018 end-page: 725 ident: bib0017 article-title: Head-to-Head Comparison of EQ-5D-3L and EQ-5D-5L Health Values publication-title: PharmacoEconomics – volume: 14 start-page: S1 year: 2013 end-page: S3 ident: bib0005 article-title: The development of new research methods for the valuation of EQ-5D-5L publication-title: Eur J Health Econ – volume: 1 start-page: e32 year: 2014 end-page: e40 ident: bib0010 article-title: Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population publication-title: The Lancet HIV – reference: Digital N. Health Survey for England: NHS Digital; 2019 [Available from: – volume: 7 start-page: e4 year: 2018 ident: bib0035 article-title: The Patient Perspective on the Impact of Tenosynovial Giant Cell Tumors on Daily Living: Crowdsourcing Study on Physical Function and Quality of Life publication-title: Interact J Med Res – volume: 8 start-page: 5 year: 2010 ident: bib0033 article-title: The health related quality of life of people living with HIV/AIDS in sub-Saharan Africa - a literature review and focus group study publication-title: Cost Eff Resour Alloc – volume: 10 start-page: 132 year: 2012 ident: bib0007 article-title: Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients publication-title: Health Qual Life Outcomes – volume: 8 start-page: 103 year: 1996 end-page: 116 ident: bib0028 article-title: Risk of HIV infection in psychiatrically ill patients publication-title: AIDS Care – volume: 192 start-page: 289 year: 2004 end-page: 296 ident: bib0029 article-title: HIV risk behavior among psychiatric outpatients: association with psychiatric disorder, substance use disorder, and gender publication-title: J Nerv Ment Dis – volume: 27 start-page: 5 year: 2013 end-page: 16 ident: bib0031 article-title: Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life publication-title: AIDS Patient Care STDS – volume: 393 start-page: 143 year: 2019 end-page: 155 ident: bib0011 article-title: Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials publication-title: Lancet – year: 2020 ident: bib0016 article-title: Positive Voices: The National Survey of People Living with HIV - findings from the 2017 survey – year: 2016 ident: bib0021 article-title: Draft global health sector strategies publication-title: HIV – reference: ECDC. HIV/AIDS surveillance in Europe 2019-2018 data European Centre for Disease Prevention and Control (ECDC) 2019. – volume: 24 start-page: 751 year: 2006 end-page: 765 ident: bib0004 article-title: A comparative review of health-related quality-of-life measures for use in HIV/AIDS clinical trials publication-title: Pharmacoeconomics – volume: 96 start-page: 1 year: 2017 end-page: 15 ident: bib0036 article-title: Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries publication-title: Journal of Hospital Infection – volume: 14 start-page: 94 year: 2016 ident: bib0012 article-title: Beyond viral suppression of HIV – the new quality of life frontier publication-title: BMC Medicine – year: 2015 ident: bib0013 publication-title: Fast Track: Ending the AIDS epidemic by 2030 – volume: 19 start-page: 343 year: 2016 end-page: 352 ident: bib0018 article-title: Dutch Tariff for the Five-Level Version of EQ-5D publication-title: Value Health – volume: 12 start-page: 465 year: 2016 end-page: 487 ident: bib0027 article-title: Mental Health in Lesbian, Gay, Bisexual, and Transgender (LGBT) Youth publication-title: Annu Rev Clin Psychol – volume: 27 start-page: 7 year: 2018 end-page: 22 ident: bib0019 article-title: Valuing health-related quality of life: An EQ-5D-5L value set for England publication-title: Health Econ – volume: 47 start-page: 384 year: 2008 end-page: 390 ident: bib0024 article-title: Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients publication-title: J Acquir Immune Defic Syndr – volume: 176 start-page: 1170 year: 2017 end-page: 1178 ident: bib0038 article-title: The burden of common skin diseases assessed with the EQ5D: a European multicentre study in 13 countries publication-title: Br J Dermatol – volume: 26 start-page: 335 year: 2012 end-page: 343 ident: bib0002 article-title: Projected life expectancy of people with HIV according to timing of diagnosis publication-title: Aids – volume: 50 start-page: 255 year: 2010 end-page: 263 ident: bib0022 article-title: Health-related quality of life and survival among HIV-infected patients receiving highly active antiretroviral therapy: a study of patients in the AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort publication-title: Clin Infect Dis – volume: 32 start-page: 103 year: 2018 end-page: 112 ident: bib0026 article-title: Health-related quality of life of people with HIV: an assessment of patient related factors and comparison with other chronic diseases publication-title: AIDS – year: 2018 ident: bib0015 article-title: Progress towards ending the HIV epidemic in the United Kingdom: 2018 report. November 2018 – volume: 26 start-page: 1555 year: 2014 end-page: 1561 ident: bib0030 article-title: Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada publication-title: AIDS Care – reference: . – volume: 37 start-page: 53 year: 1996 end-page: 72 ident: bib0009 article-title: EuroQol: the current state of play publication-title: Health Policy – volume: 66 start-page: 769 year: 2006 end-page: 789 ident: bib0023 article-title: Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy publication-title: Drugs – volume: 11 start-page: 164 year: 2013 ident: bib0034 article-title: Patient reported outcome instruments used in clinical trials of HIV-infected adults on NNRTI-based therapy: a 10-year review publication-title: Health Qual Life Outcomes – volume: 21 start-page: 14 year: 2008 end-page: 18 ident: bib0025 article-title: Major depression and comorbid substance use disorders publication-title: Curr Opin Psychiatry – volume: 11 start-page: 42 year: 2013 ident: bib0008 article-title: Responsiveness of the MOS-HIV and EQ-5D in HIV-infected adults receiving antiretroviral therapies publication-title: Health and quality of life outcomes – reference: National AIDS programmes: A guid to monitoring and evaluation UNAIDS; 2000. – year: 2017 ident: bib0014 article-title: Monitoring Report 2017 publication-title: Humaan Immunodeficiency Virus (HIV) Infection in the Netherlands – volume: 50 start-page: 255 issue: 2 year: 2010 ident: 10.1016/j.lanepe.2021.100177_bib0022 article-title: Health-related quality of life and survival among HIV-infected patients receiving highly active antiretroviral therapy: a study of patients in the AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort publication-title: Clin Infect Dis doi: 10.1086/649216 – volume: 25 start-page: 451 issue: 4 year: 2013 ident: 10.1016/j.lanepe.2021.100177_bib0032 article-title: Chronic illness burden and quality of life in an aging HIV population publication-title: AIDS Care doi: 10.1080/09540121.2012.712669 – volume: 24 start-page: 751 issue: 8 year: 2006 ident: 10.1016/j.lanepe.2021.100177_bib0004 article-title: A comparative review of health-related quality-of-life measures for use in HIV/AIDS clinical trials publication-title: Pharmacoeconomics doi: 10.2165/00019053-200624080-00003 – volume: 19 start-page: 343 issue: 4 year: 2016 ident: 10.1016/j.lanepe.2021.100177_bib0018 article-title: Dutch Tariff for the Five-Level Version of EQ-5D publication-title: Value Health doi: 10.1016/j.jval.2016.01.003 – volume: 26 start-page: 1555 issue: 12 year: 2014 ident: 10.1016/j.lanepe.2021.100177_bib0030 article-title: Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada publication-title: AIDS Care doi: 10.1080/09540121.2014.936813 – volume: 176 start-page: 1170 issue: 5 year: 2017 ident: 10.1016/j.lanepe.2021.100177_bib0038 article-title: The burden of common skin diseases assessed with the EQ5D: a European multicentre study in 13 countries publication-title: Br J Dermatol doi: 10.1111/bjd.15280 – year: 2017 ident: 10.1016/j.lanepe.2021.100177_bib0014 article-title: Monitoring Report 2017 publication-title: Humaan Immunodeficiency Virus (HIV) Infection in the Netherlands – year: 2016 ident: 10.1016/j.lanepe.2021.100177_bib0021 article-title: Draft global health sector strategies publication-title: HIV – volume: 10 start-page: 132 year: 2012 ident: 10.1016/j.lanepe.2021.100177_bib0007 article-title: Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients publication-title: Health Qual Life Outcomes doi: 10.1186/1477-7525-10-132 – volume: 27 start-page: 7 issue: 1 year: 2018 ident: 10.1016/j.lanepe.2021.100177_bib0019 article-title: Valuing health-related quality of life: An EQ-5D-5L value set for England publication-title: Health Econ doi: 10.1002/hec.3564 – volume: 21 start-page: 14 issue: 1 year: 2008 ident: 10.1016/j.lanepe.2021.100177_bib0025 article-title: Major depression and comorbid substance use disorders publication-title: Curr Opin Psychiatry doi: 10.1097/YCO.0b013e3282f32408 – year: 2020 ident: 10.1016/j.lanepe.2021.100177_bib0016 – year: 2015 ident: 10.1016/j.lanepe.2021.100177_bib0013 publication-title: Fast Track: Ending the AIDS epidemic by 2030 – volume: 12 start-page: 465 year: 2016 ident: 10.1016/j.lanepe.2021.100177_bib0027 article-title: Mental Health in Lesbian, Gay, Bisexual, and Transgender (LGBT) Youth publication-title: Annu Rev Clin Psychol doi: 10.1146/annurev-clinpsy-021815-093153 – volume: 7 start-page: e4 issue: 1 year: 2018 ident: 10.1016/j.lanepe.2021.100177_bib0035 article-title: The Patient Perspective on the Impact of Tenosynovial Giant Cell Tumors on Daily Living: Crowdsourcing Study on Physical Function and Quality of Life publication-title: Interact J Med Res doi: 10.2196/ijmr.9325 – volume: 393 start-page: 143 issue: 10167 year: 2019 ident: 10.1016/j.lanepe.2021.100177_bib0011 publication-title: Lancet doi: 10.1016/S0140-6736(18)32462-0 – volume: 47 start-page: 384 issue: 3 year: 2008 ident: 10.1016/j.lanepe.2021.100177_bib0024 article-title: Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0b013e318160d53e – volume: 66 start-page: 769 issue: 6 year: 2006 ident: 10.1016/j.lanepe.2021.100177_bib0023 article-title: Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy publication-title: Drugs doi: 10.2165/00003495-200666060-00004 – volume: 192 start-page: 289 issue: 4 year: 2004 ident: 10.1016/j.lanepe.2021.100177_bib0029 article-title: HIV risk behavior among psychiatric outpatients: association with psychiatric disorder, substance use disorder, and gender publication-title: J Nerv Ment Dis doi: 10.1097/01.nmd.0000120888.45094.38 – volume: 8 start-page: 5 year: 2010 ident: 10.1016/j.lanepe.2021.100177_bib0033 article-title: The health related quality of life of people living with HIV/AIDS in sub-Saharan Africa - a literature review and focus group study publication-title: Cost Eff Resour Alloc doi: 10.1186/1478-7547-8-5 – ident: 10.1016/j.lanepe.2021.100177_bib0003 – ident: 10.1016/j.lanepe.2021.100177_bib0001 – volume: 11 start-page: 42 year: 2013 ident: 10.1016/j.lanepe.2021.100177_bib0008 article-title: Responsiveness of the MOS-HIV and EQ-5D in HIV-infected adults receiving antiretroviral therapies publication-title: Health and quality of life outcomes doi: 10.1186/1477-7525-11-42 – volume: 27 start-page: 5 issue: 1 year: 2013 ident: 10.1016/j.lanepe.2021.100177_bib0031 article-title: Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life publication-title: AIDS Patient Care STDS doi: 10.1089/apc.2012.0329 – ident: 10.1016/j.lanepe.2021.100177_bib0020 – volume: 14 start-page: 94 issue: 1 year: 2016 ident: 10.1016/j.lanepe.2021.100177_bib0012 article-title: Beyond viral suppression of HIV – the new quality of life frontier publication-title: BMC Medicine doi: 10.1186/s12916-016-0640-4 – volume: 14 start-page: S1 issue: 1 year: 2013 ident: 10.1016/j.lanepe.2021.100177_bib0005 article-title: The development of new research methods for the valuation of EQ-5D-5L publication-title: Eur J Health Econ doi: 10.1007/s10198-013-0502-3 – volume: 8 start-page: 103 issue: 1 year: 1996 ident: 10.1016/j.lanepe.2021.100177_bib0028 article-title: Risk of HIV infection in psychiatrically ill patients publication-title: AIDS Care doi: 10.1080/09540129650126037 – year: 2018 ident: 10.1016/j.lanepe.2021.100177_bib0015 – volume: 1 start-page: e32 year: 2014 ident: 10.1016/j.lanepe.2021.100177_bib0010 article-title: Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population publication-title: The Lancet HIV doi: 10.1016/S2352-3018(14)70018-9 – volume: 26 start-page: 335 issue: 3 year: 2012 ident: 10.1016/j.lanepe.2021.100177_bib0002 article-title: Projected life expectancy of people with HIV according to timing of diagnosis publication-title: Aids doi: 10.1097/QAD.0b013e32834dcec9 – volume: 32 start-page: 103 issue: 1 year: 2018 ident: 10.1016/j.lanepe.2021.100177_bib0026 article-title: Health-related quality of life of people with HIV: an assessment of patient related factors and comparison with other chronic diseases publication-title: AIDS doi: 10.1097/QAD.0000000000001672 – volume: 15 start-page: 220 issue: 1 year: 2017 ident: 10.1016/j.lanepe.2021.100177_bib0006 article-title: Measuring quality of life among people living with HIV: a systematic review of reviews publication-title: Health Qual Life Outcomes doi: 10.1186/s12955-017-0778-6 – volume: 37 start-page: 53 issue: 1 year: 1996 ident: 10.1016/j.lanepe.2021.100177_bib0009 article-title: EuroQol: the current state of play publication-title: Health Policy doi: 10.1016/0168-8510(96)00822-6 – volume: 11 start-page: 164 year: 2013 ident: 10.1016/j.lanepe.2021.100177_bib0034 article-title: Patient reported outcome instruments used in clinical trials of HIV-infected adults on NNRTI-based therapy: a 10-year review publication-title: Health Qual Life Outcomes doi: 10.1186/1477-7525-11-164 – volume: 35 start-page: 957 issue: 6 year: 2021 ident: 10.1016/j.lanepe.2021.100177_bib0039 article-title: Worldwide relative smoking prevalence among people living with and without HIV publication-title: Aids doi: 10.1097/QAD.0000000000002815 – volume: 96 start-page: 1 issue: 1 year: 2017 ident: 10.1016/j.lanepe.2021.100177_bib0036 article-title: Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries publication-title: Journal of Hospital Infection doi: 10.1016/j.jhin.2017.03.004 – volume: 36 start-page: 715 issue: 6 year: 2018 ident: 10.1016/j.lanepe.2021.100177_bib0017 article-title: Head-to-Head Comparison of EQ-5D-3L and EQ-5D-5L Health Values publication-title: PharmacoEconomics doi: 10.1007/s40273-018-0647-0 |
| SSID | ssj0002513214 |
| Score | 2.3423936 |
| Snippet | HIV is now considered a chronic condition, and people living with HIV, when treated, have a similar life expectancy as compared to the general population.... AbstractBackgroundHIV is now considered a chronic condition, and people living with HIV, when treated, have a similar life expectancy as compared to the... Background: HIV is now considered a chronic condition, and people living with HIV, when treated, have a similar life expectancy as compared to the general... |
| SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 100177 |
| SubjectTerms | elimination goals HIV Internal Medicine people living with HIV Public Health quality of life Research Paper value-based healthcare |
| Title | Quality of life among people living with HIV in England and the Netherlands: a population-based study |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S266677622100154X https://www.clinicalkey.es/playcontent/1-s2.0-S266677622100154X https://dx.doi.org/10.1016/j.lanepe.2021.100177 https://www.ncbi.nlm.nih.gov/pubmed/34557859 https://www.proquest.com/docview/2576651018 https://pubmed.ncbi.nlm.nih.gov/PMC8454587 https://doaj.org/article/58f05094b58f4df688b94e4cc08d1bb8 |
| Volume | 8 |
| WOSCitedRecordID | wos000704988300020&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2666-7762 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002513214 issn: 2666-7762 databaseCode: DOA dateStart: 20210101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2666-7762 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002513214 issn: 2666-7762 databaseCode: M~E dateStart: 20200101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Pi9UwEA66ePAiir_eqksEr8W0SZN0byq7rKCLoC7vFpImwSdL32P7VvCyf7szSftoVXgePLSUNmnozHRm0n75hpBXZeVaYZ0sgoe5qnAC_KC1CFzDEnBctjYBZC8-qPNzvVw2nyalvhATlumBs-Be1zoiRYlwcCB8lFq7RgTRtkz70rm0zJepZjKZQh8MURsr8GBlOcjPIYWU1bhuLoG7EEi6QZbMqkwsRErN4lKi75-Fpz_Tz99RlJOwdHqf3BvySfomP8cDcit0D0nIzBg_6TrSy1UMNJUUohktDmfwIwLFL7D07P0FXXV0KOVBcYOMkE6WAR9TSze7Kl8FRj1PEyntI_L19OTLu7NiqKdQtJKrbSGsaKxVqpaitNpqzzn4SZhQhGCjDNFFyWIlLAjbSs4bX4Miq7ZkEZKW0ln-mBx06y48JZRzL3nU2jcSWrNWsyCcL5VlnjHYLQgfpWnagWwca15cmhFV9t1kHRjUgck6WJBi12uTyTb2tH-Litq1RarsdAIMyAwGZPYZ0ILUo5rNuBoV_CfcaLVncPW3fqEfnEBvStNXhpnPaIJogVWZMtbltOeQ5-T85R_GfDnaoQE3gP92oM36ujc4b5SJfm1BnmS73ImFixopjRoYd2axM7nNr3Srb4lqXAv8saoO_4egn5G7-CgZoPecHGyvrsMLcqf9sV31V0fktlrqo_QWw_7jzckv0KBLNw |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quality+of+life+among+people+living+with+HIV+in+England+and+the+Netherlands%3A+a+population-based+study&rft.jtitle=The+Lancet+regional+health.+Europe&rft.au=Popping%2C+Stephanie&rft.au=Kall%2C+Meaghan&rft.au=Nichols%2C+Brooke+E.&rft.au=Stempher%2C+Evelien&rft.date=2021-09-01&rft.pub=Elsevier+Ltd&rft.issn=2666-7762&rft.eissn=2666-7762&rft.volume=8&rft_id=info:doi/10.1016%2Fj.lanepe.2021.100177&rft.externalDocID=S266677622100154X |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F26667762%2FS2666776221X00099%2Fcov150h.gif |